GOZILA ( Guardant Originates in ZIpangu Liquid biopsy Arrival) trial will initially use Guardant360 to test 200 advanced CRC patients
Original Article: Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of GI Cancer Trial
NEXT ARTICLE